Patents

The intellectual property resulting from translational research carried out in IrsiCaixa fosters technological development and new products and processes in the benefit of society.

Granted

Human helicase DDX3 inhibitors as therapeutic agents

Inventor

Miguel Ángel Martínez de la Sierra

Reference

WO/2016/128541; PCT/EP2016/052990
Method for identifying HIV neutralizing antibodies

Inventor

Jorge Carrillo Molina

Julià Blanco Arbués

Reference

WO/2014/037490; PCT/EP2013/068446
Method for monitoring HIV specific T cell responses

Inventor

Marta Ruiz Riol

Christian Brander

Reference

WO/2013/139972; PCT/EP2013/056110
Inhibitors of sialoadhesin for the treatment of diseases caused by enveloped viruses

Inventor

Nuria Izquierdo Useros

Javier Martínez-Picado

Reference

WO/2013/092509; PCT/EP2012/075831

Published

HIV antibody derivatives with dual antiviral and immunomodulatory activity

Inventor

Bonaventura Clotet Sala

Jorge Carrillo Molina

Julià Blanco Arbués

Reference

WO/2017/085563; PCT/IB2016/001868
Aurora kinase inhibitors for treating or preventing HIV infection or AIDS

Inventor

Edurne García Vidal

Roger Badia Córcoles

Eva Riveira Muñoz

Ester Ballana Guix

Reference

WO/2020/049208; PCT/ES2019/070596
Virus Like Particles with high density coating for inucing the expression of antibodies

Inventor

Jorge Carrillo Molina

Julià Blanco Arbués

Reference

WO/2018/020324; PCT/IB2017/001101

Filed

Polypeptides for eliciting humoral and cellular immune responses against coronavirus infections

Inventor

Julia García Prado

Christian Brander
Siglec-1 monoclonal antibodies for treating and preventing HIV-1 and Ebola virus infections

Inventor

Nuria Izquierdo Useros

Javier Martínez-Picado

Daniel Pérez Zsolt

Patricia Resa Infante

Reference

62828195 (US)